Personal CFO Solutions’s iRadimed IRMD Stock Holding History

Personal CFO Solutions’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$221K	Buy	+2,311	New	+$210K	0.03%	493

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Personal CFO Solutions's IRMD Position: Q2 2026 in Review

Personal CFO Solutions opened a new position in iRadimed (IRMD) in Q2 2026: 2,311 shares worth $221K. The stake represents 0.03% of the portfolio and ranks #493 among its holdings.

214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Personal CFO Solutions held 2,311 shares of iRadimed worth $221K as of Q2 2026.
iRadimed was a new Personal CFO Solutions position in Q2 2026.
iRadimed made up 0.03% of Personal CFO Solutions's portfolio in Q2 2026, its #493 holding.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Personal CFO Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.